6
Participants
Start Date
September 30, 2013
Primary Completion Date
January 31, 2015
Study Completion Date
June 30, 2016
Sativex
Administered orally as a spray to the cheek according to a standard dose titration regimen, until patients reach a maximum tolerated dose (maximum 12 sprays per day). Each spray delivers 100 μl (Δ9tetrahydrocannabinol (THC), 27 mg/ml: Cannabidiol (CBD), 25 mg/ml).
The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington
St James's Institute of Oncology, St James's University Hospital, Leeds
Bristol Haematology & Oncology Centre, Bristol
Guy's and St Thomas NHS Foundation Trust, of St Thomas' Hospital, London
The Christie NHS Foundation Trust, Manchester
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY